Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2002-12-23
pubmed:abstractText
This multinational retrospective study compares the outcomes of patients with primary mediastinal large B-cell lymphoma (PMLBCL) with sclerosis after first-generation (dose-intensive regimens), third-generation (alternating regimens) and high-dose chemotherapy strategies, frequently with adjuvant radiation therapy.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0390-6078
pubmed:author
pubmed-author:AlinariLapoL, pubmed-author:AngelopoulouMaria KMK, pubmed-author:BalzarottiMonicaM, pubmed-author:BertiniMarilenaM, pubmed-author:BonifaziFrancescaF, pubmed-author:BrugiatelliMauraM, pubmed-author:CalderoniAntonelloA, pubmed-author:CantonettiMariaM, pubmed-author:CavalliFrancoF, pubmed-author:CortelazzoSergioS, pubmed-author:De RenzoAmaliaA, pubmed-author:DevizziLilianaL, pubmed-author:Di RenzoNicolaN, pubmed-author:FaliniBrunangeloB, pubmed-author:FattoriPier PaoloPP, pubmed-author:FedericoMassimoM, pubmed-author:FerreriAndrés J MAJ, pubmed-author:GentiliniPatriziaP, pubmed-author:GianniAlessandro MAM, pubmed-author:International Extranodal Lymphoma Study Group (IELSG), pubmed-author:LauriaFrancescoF, pubmed-author:LiberatiMarina AMA, pubmed-author:MartelliMaurizioM, pubmed-author:MichelsJorgJ, pubmed-author:PangalisGerassimosG, pubmed-author:PavoneEnzoE, pubmed-author:PileriStefano ASA, pubmed-author:WotherspoonAndrewA, pubmed-author:ZaccariaAlfonsoA, pubmed-author:ZajaFrancescoF, pubmed-author:ZinzaniPier LuigiPL, pubmed-author:ZuccaEmanueleE
pubmed:issnType
Print
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1258-64
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients.
pubmed:affiliation
Institute of Hematology and Medical Oncology Seràgnoli, University of Bologna, Italy. plzinzo@med.unibo.it
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't